C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $699,094 | -32.4% | 375,857 | 0.0% | 0.21% | -39.6% |
| Q2 2023 | $1,033,607 | -12.4% | 375,857 | 0.0% | 0.35% | -28.8% |
| Q1 2023 | $1,180,191 | -46.8% | 375,857 | 0.0% | 0.49% | -44.1% |
| Q4 2022 | $2,217,556 | -32.7% | 375,857 | 0.0% | 0.88% | -17.2% |
| Q3 2022 | $3,296,000 | +16.3% | 375,857 | 0.0% | 1.06% | +11.4% |
| Q2 2022 | $2,834,000 | -68.9% | 375,857 | 0.0% | 0.96% | -63.3% |
| Q1 2022 | $9,118,000 | -24.7% | 375,857 | 0.0% | 2.60% | -18.4% |
| Q4 2021 | $12,103,000 | – | 375,857 | – | 3.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |